Navigation Links
Ebola Treatment Shows Promise

Researchers publishing in the most recent issue of The Lancet believe they’re on the track to a possible treatment for the deadly Ebola virus.//

In a study conducted in rhesus monkeys, researchers found injections of a factor known to inhibit blood coagulation called rNAPc2 led to increased survival rates.

The Ebola virus kills its victims by causing severe hemorrhagic fever. This leads to excessive coagulation of the blood and, ultimately, organ failure. In outbreaks in Zaire, about 80 percent of people who contracted the virus died. The death rate in monkey models of the disease has been nearly 100 percent. These researchers wondered if the disease could be stopped by using rNAPc2 to inhibit the blood coagulation pathway.

Researchers from the United States Army Medical Research Institute of Infectious Diseases tested the treatment in nine monkeys who were intentionally infected with the virus. Three additional monkeys were infected with the virus but received no treatment and served as controls. Results show the treatment prolonged survival time. What’s more, 33 percent of the treated monkeys actually survived the disease and regained their health. Just one of the monkeys in the control group survived until the end of the study, and that monkey subsequently died.

The authors write, “Our results have great clinical implications, since our treatment approach of Ebola hemorrhagic fever targets the disease process rather than replication of the infectious agent.” Noting rNAPc2 has a good safety profile in humans, they believe it might also have a role to play in other viral hemorrhagic fevers. “The clinical efficacy of this treatment modality now needs to be proven,” they conclude.

'"/>




Page: 1

Related medicine news :

1. Ebola Virus - Outbreak Claims More Lives In Uganda.
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. Ebola-like virus is on the way to cause epidemic in Angola
4. Fruit Bats Act As Carriers of Ebola Virus
5. Antisense gene specific therapy for Ebola virus
6. Ebola-Outbreak Kills 5000 Gorillas
7. Research on Vaccine Against Ebola Virus
8. Advances in Treatment of Cataracts
9. Recommendations for Treatment of Blood Pressue
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... The V ... announce its Not a Moment to Lose fundraising campaign. As the V Foundation’s ... to declaring victory over cancer. The campaign aims to raise $200 million by ...
(Date:12/6/2016)... ... 2016 , ... GrekTek LLC, ( http://www.grektek.com ) an mHealth ... ) for the HealthyWatch, a new device to help patients manage their health ... while sharing these events with caregivers in real time. , “One ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... to understand the scope of their EHS regulatory obligations and rapidly collect, share, ...
(Date:12/5/2016)... ... December 05, 2016 , ... What: Shriners Hospitals for Children, with the help ... patients – using a video monitor and web-enabled camera. Santa visits with children through ... into a Christmas Wonderland, which is where the video connection to the North Pole ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... it has been featured in SuperbCrew magazine, a leading online tech news platform ... This interview, now featured on SuperbCrew.com, explores the state of enterprise mobility security ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016  Sharn Anesthesia Inc. announced today ... and distribution partner for Salter Labs.  The company also ... in recognition of outstanding sales performance. Salter ... and anesthesia care, including the market gold standard ECO ... master distributor of the Parker Flex-Tip® Endotracheal Tube, which ...
(Date:12/5/2016)... , Dec. 5, 2016   BIOTRONIK today ... study. The study evaluates the safety and feasibility of ... an office setting. BioMonitor 2 is an ... that is placed underneath a patient,s skin to help ... (fainting). Atrial fibrillation is a leading cause of stroke ...
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sanovas, ... technology accelerator, announced today the launch of its wholly owned ... Logo - http://photos.prnewswire.com/prnh/20161202/445250LOGO   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO ... ... There ...
Breaking Medicine Technology: